Wenatchee Valley Medical Center
Employment Patient Resources Billing and Insurance Physician Directory Locations News and Events About Us Home
Printer Friendly Version
  » Advanced Search
 

About Trials

 

Enrolling Studies

 

Inquiry Form

  Contact   Patients Home

Clinical Research Opportunities

We are frequently starting new studies, and this page is updated on a monthly basis. You may want to add this to your "Favorites List".

Patients are currently being recruited for the following research studies. Some of the studies have additional information available when you click on the study name.

CURRENT STUDIES:
Acute Shingles
Breast Cancer with Prior Treatment
Constipation
Heartburn and GERD
Insomnia
Migraine Prophylaxis
Multiple Myeloma
Osteoarthritis/Rheumatoid Arthritis
Recurrent Ovarian Cancer
SWOG / PSOC / GOG / RTOG / SCCA
Type 2 Diabetes

 

Acute Shingles

The Clinical Research Department at Wenatchee Valley Medical Center is currently looking for patients with a new diagnosis of Herpes Zoster (shingles). The shingles rash can only have been present for 72 hours or less.  Patients must be willing to come in every day for the first week, followed by weekly follow-up visits for the next 3 weeks.  Additional follow-up may be required.  Qualifying patients will be compensated.  
For more information:
Phone: 509-665-5800




Breast Cancer with Prior Treatment

The Clinical Research Department at Wenatchee Valley Medical Center is currently conducting a study for breast cancer patients who have received one or two prior chemotherapy treatments and have locally advanced or metastatic disease.  Patients will receive either an investigational drug infusion or an already approved oral treatment.  Patients will also receive study related physical examinations, laboratory tests, and CT or MRI scans during the study.
For more information:
Phone: 509-665-5800

 

Constipation

The Clinical Research Department at Wenatchee Valley Medical Center is currently conducting a study for Constipation.  Researchers are evaluating an investigational medication to see if it effectively treats Constipation.  You may qualify for this research study if you experience any of the following symptoms:
        * Abdominal pain or discomfort
        * Bloating and/or straining
        * Having fewer than 3 bowel movements per week
All study-related care will be provided at no cost.  Insurance is not needed.
For more information:
Phone: 509-665-5800

                    


Heartburn and GERD

Do you have a history of GERD symptoms such as acid reflux or dyspepsia?  Do you suffer from heartburn at least 2 days a week?  The research department at Wenatchee Valley Medical Center is conducting a study on erosive esophagitis based on these symptoms.  Males and females aged 18 to 75 that are eligible will receive study-related medical care, regular study check-ups, and study medication at no charge.  This study may last up to 14 weeks and participants may be compensated for time and travel. 
For more information:
Phone: 509-665-5800





Insomnia: 
Have trouble sleeping?  Wake up during the night?  The Research Department at Wenatchee Valley Medical Center is conducting a research study of a new medication for the treatment of insomnia.  If you are between the ages of 18 and 65 and frequently have trouble sleeping and do not have any other sleep disorders such as apnea or restless legs, you may qualify.  This study may last up to 26 weeks and compensation for time and travel may be provided.
For more information:
Phone: 509-665-5800




Migraine Prophylaxis: 
The Clinical Research Department is currently enrolling patients in a clinical research study of an investigational medication that may prevent migraines in adults.  To qualify, you must be 18 years of age or older and suffer from migraines.  Qualifying participants may receive, study-related testing, monitoring by health care professionals, study visit and study-related health care at no cost and possible compensation for time and travel.
For more information:
Phone: 509-665-5800

 


Multiple Myeloma

WVMC Clinical Research Department and the Oncology department are conducting a study for patients with multiple myeloma.  Qualified participants cannot be a candidate for high-dose chemotherapy or stem cell transplant.  Patients must have measurable disease requiring systemic therapy.  Participants will be randomized to one of three treatment arms.  Duration of the study is approximately 4 years.
For more information:
Phone: 509-665-5800

 


Osteoarthritis / Rheumatoid Arthritis

Bothered by Arthritis?  Concerned about Heart Disease?  The Clinical Research department is conducting a research study of 3 approved medications commonly used to treat pain due to osteoarthritis (OA) or rheumatoid arthritis (RA) in people who also have or at high risk for heart disease.  Qualified participations will receive study-related medical care, regular study checkups, and study medication at no charge.

To qualify you must:
            *Be 18 years of age or older
            *Have had osteoarthritis or rheumatoid arthritis for at least 6 months
            *Have been prescribed regular medication for your pain for at least 6              months
            *Have or be at high risk for heart disease, which includes a history of
              heart attack, stroke, or diabetes                          
For more information:
Phone: 509-665-5800

 


Recurrent Ovarian Cancer

For patients who have had a diagnosis of recurrent ovarian, primary peritoneal or fallopian tube cancer.  Participants must have recurrence > 6 months since the last chemotherapy treatment.  Patients will have 6 cycles of chemotherapy, with an additional 4 cycles given as determined by the oncologist.
For more information:
Phone: 509-665-5800

 


SWOG / PSOC / GOG / RTOG / SCCA

Wenatchee Valley Medical Center Cancer Care Center participates in multiple clinical research studies to assess the effect of investigational treatments for cancer patients.  The studies are offered through affiliation with the Southwest Oncology Group (SWOG), Puget Sound Oncology Group (RTOG), and Seattle Cancer Care Alliance (SCCA).
For more information contact your medical or radiation oncologist.

 


Type 2 Diabetes

To qualify for this study patients must be using metformin (alone) to treat their diabetes at a stable dose of 1500-2000 mg.  Participants may be male or female 18 to 78 years of age, without active liver disease, kidney disease or congestive heart failure.  This study will provide 24 weeks of diabetes treatment and will require 8 medical center visits.  Patients will be compensated for time and travel. 
For more information:
Phone: 509-665-5800

 

 



 

 



 

 

Site Design by Sun Graphic and Computerworks